Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Dalton Trans ; 51(46): 17671-17687, 2022 Nov 29.
Article in English | MEDLINE | ID: mdl-36342366

ABSTRACT

Since the interfacial binding strength and structural integrity have a strong influence on the active sites of nanocomposites, this study focused on exploring the structural and electronic properties at the interface between the implanted metal ion and host support. For this, nanocomposites of gold embedded in CeO2-ZrO2 and CeO2-Al2O3 matrices were fabricated, and their structural and morphological properties were investigated using ICP-OES, UV-vis, XRD, Raman, HRTEM, and high-resolution XPS studies and compared. From the results, it was found that the deposition of gold is highly favored over CeO2-ZrO2 (3.99 atomic %) than CeO2-Al2O3 (1.21 atomic %); however, the same amount of gold was used for the synthesis of both nanocomposites, as befits it. The HRTEM images of Au/CeO2-ZrO2 displayed well-organized yarn textured particles with less than 5 nm size, which lacks in Au/CeO2-Al2O3. The reason for this less systematized and less Au embedding in the presence of alumina in CeO2-Al2O3 was verified with the high-resolution XPS studies of both nanocomposites and an elevated binding energy due to the mobility of Au particles over CeO2-Al2O3 was observed, while for Au/CeO2-ZrO2, a very small binding energy shift of gold states (Au 4f5/2 0.39; Au 4f7/2 0.17 eV) and the CeO2-ZrO2 matrix that favored an increased intermolecular force between gold and the supporting host was observed. This agrees well with UV-vis electronic spectrum analysis, which revealed that the incorporation of gold nanoparticles narrowed the band gap more significantly in Au/CeO2-ZrO2 (4.2 eV) than Au/CeO2-Al2O3 (4.94 eV) suggesting the elevated electron transfer from the conduction band of CeO2-ZrO2 to Au interfaces. In addition, XRD and Raman studies of Au/CeO2-ZrO2 showed a pronounced phase transformation of Ce4+ to Ce3+ in the presence of homovalent Zr4+ ions with an increased structural disorder in CeO2 promoting the localized surface plasmon resonance (LSPR) in the lattice of CeO2-ZrO2, which was less detected in Au/CeO2-Al2O3 due to the interference of less-desired γ-Al2O3 phases. These characteristics of Au/CeO2-ZrO2 ensured its performance as a promised photocatalyst for thioanisole degradation without using any harmful oxidants, and its stability towards different irradiation conditions, such as visible, ultraviolet, and solar light.

2.
Molecules ; 25(22)2020 Nov 20.
Article in English | MEDLINE | ID: mdl-33233564

ABSTRACT

Doxorubicin (Dox) is the most widely used chemotherapeutic agent and is considered a highly powerful and broad-spectrum for cancer treatment. However, its application is compromised by the cumulative side effect of dose-dependent cardiotoxicity. Because of this, targeted drug delivery systems (DDS) are currently being explored in an attempt to reduce Dox systemic side-effects. In this study, DDS targeting hepatocellular carcinoma (HCC) has been designed, specifically to the asialoglycoprotein receptor (ASGPR). Dox-loaded albumin-albumin/lactosylated (core-shell) nanoparticles (tBSA/BSALac NPs) with low (LC) and high (HC) crosslink using glutaraldehyde were synthesized. Nanoparticles presented spherical shapes with a size distribution of 257 ± 14 nm and 254 ± 14 nm, as well as an estimated surface charge of -28.0 ± 0.1 mV and -26.0 ± 0.2 mV, respectively. The encapsulation efficiency of Dox for the two types of nanoparticles was higher than 80%. The in vitro drug release results showed a sustained and controlled release profile. Additionally, the nanoparticles were revealed to be biocompatible with red blood cells (RBCs) and human liver cancer cells (HepG2 cells). In cytotoxicity assays, Dox-loaded nanoparticles decrease cell viability more efficiently than free Dox. Specific biorecognition assays confirmed the interaction between nanoparticles and HepG2 cells, especially with ASGPRs. Both types of nanoparticles may be possible DDS specifically targeting HCC, thus reducing side effects, mainly cardiotoxicity. Therefore, improving the quality of life from patients during chemotherapy.


Subject(s)
Albumins/chemistry , Antineoplastic Agents/administration & dosage , Doxorubicin/administration & dosage , Drug Carriers/chemistry , Drug Delivery Systems , Lactose/chemistry , Nanoparticles/chemistry , Animals , Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/pathology , Cell Line, Tumor , Cell Survival/drug effects , Chemical Phenomena , Delayed-Action Preparations , Disease Models, Animal , Drug Liberation , Erythrocytes/drug effects , Hemolysis , Humans , Liver Neoplasms/drug therapy , Liver Neoplasms/pathology , Particle Size
SELECTION OF CITATIONS
SEARCH DETAIL
...